Work

Abstract 438: The multibody drug conjugate (MDC) BD200 mediates anti-tumor activity through a novel dual-targeting mode.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-438

Authors: Michael D. Oberst, Dror Luger, Micheal Kebede, Devi Gunasekera, Meital Gadrich, Yonit Ben David, Leah Asulin, Noam Grossman, Reut Fuchs, Hezi Sasson, Yael Diesendruck, Guy Nimrod, Tim Wyant, Ronald Herbst, Yanay Ofran, Inbar Amit

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148860013

Cites:

Cited by:

Related to: